Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining - PubMed (original) (raw)

. 1973 Jun 1;243(5405):290-3.

doi: 10.1038/243290a0.

• PMID: 4126434
• DOI: 10.1038/243290a0

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

J D Rowley. Nature. 1973.

No abstract available

PubMed Disclaimer

Similar articles

• Heterogeneity of Ph1 in chronic myeloid leukaemia.
  Mitelman F. Mitelman F. Hereditas. 1974;76(2):315-6. doi: 10.1111/j.1601-5223.1974.tb01347.x. Hereditas. 1974. PMID: 4135826 No abstract available.
• Identification of chromosome anomalies in the blastic phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding techniques.
  Hossfeld DK. Hossfeld DK. Humangenetik. 1974 Jul 15;23(2):111-8. doi: 10.1007/BF00282208. Humangenetik. 1974. PMID: 4136793 No abstract available.
• Absence of the 9q plus chromosome in Ph1 negative chronic myelogenous leukaemia.
  Rowley JD. Rowley JD. J Med Genet. 1974 Jun;11(2):166-70. doi: 10.1136/jmg.11.2.166. J Med Genet. 1974. PMID: 4135401 Free PMC article.
• The Philadelphia chromosome.
  Baserga A, Castoldi GL. Baserga A, et al. Biomedicine. 1973 Mar;18(2):89-94. Biomedicine. 1973. PMID: 4125985 Review. No abstract available.
• Ph1-positive leukaemia, including chronic myelogenous leukaemia.
  Rowley JD. Rowley JD. Clin Haematol. 1980 Feb;9(1):55-86. Clin Haematol. 1980. PMID: 6245823 Review. No abstract available.

Cited by

• Overview of Myeloproliferative Neoplasms: History, Pathogenesis, Diagnostic Criteria, and Complications.
  Tremblay D, Yacoub A, Hoffman R. Tremblay D, et al. Hematol Oncol Clin North Am. 2021 Apr;35(2):159-176. doi: 10.1016/j.hoc.2020.12.001. Epub 2021 Jan 26. Hematol Oncol Clin North Am. 2021. PMID: 33641861 Free PMC article. Review.
• Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia.
  Madejczyk AM, Canzian F, Góra-Tybor J, Campa D, Sacha T, Link-Lenczowska D, Florek I, Prejzner W, Całbecka M, Rymko M, Dudziński M, Orzechowska MJ, Jamroziak K. Madejczyk AM, et al. Front Oncol. 2022 Sep 23;12:952640. doi: 10.3389/fonc.2022.952640. eCollection 2022. Front Oncol. 2022. PMID: 36212403 Free PMC article.
• Chromosomal Rearrangements in Cancer: Detection and potential causal mechanisms.
  Hasty P, Montagna C. Hasty P, et al. Mol Cell Oncol. 2014 Jul;1(1):e29904. doi: 10.4161/mco.29904. Mol Cell Oncol. 2014. PMID: 26203462 Free PMC article.
• Synthesis and Anticancer Activities of Novel Guanylhydrazone and Aminoguanidine Tetrahydropyran Derivatives.
  Silva FP, Dantas BB, Faheina Martins GV, de Araújo DA, Vasconcellos ML. Silva FP, et al. Molecules. 2016 Jun 21;21(6):671. doi: 10.3390/molecules21060671. Molecules. 2016. PMID: 27338323 Free PMC article.
• Cytogenetics: past, present and future.
  Kannan TP, Zilfalil BA. Kannan TP, et al. Malays J Med Sci. 2009 Apr;16(2):4-9. Malays J Med Sci. 2009. PMID: 22589651 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database